| Limited heart failure data in Asia |
• Improve granularity and quality of heart failure registry data with the ability to harmonize other regional heart failure registries. |
| • Recognize the diversity of Asian ancestry and its implication on heart failure presentation, management, and outcome. |
| • Improve understanding of environmental, dietary, genetic factors on heart failure in Asia. |
| • Investment of genomic research infrastructure including development of biobanks for various Asian communities. |
| • Continue participation in global clinical trials for heart failure. Current trial participants are representative of clinical practice. |
| Non-optimal guideline directed medication and device use |
• Emphasis on implementation science research to contextualize and scale-up interventions to improve guideline directed care in each country. |
| • Address patient-related, treatment-related, healthcare-related factors unique to Asian countries that may lead to non-optimal use of medication and device use. |
| • Heart failure polypill in development to address adherence and reduce pill burden. |
| • Improve standards of heart failure care through a multidisciplinary team approach. |
| Inadequate training opportunities for providers |
• Expand training programs for healthcare providers, including non-cardiologists, in heart failure management. |
| • Re-vamp training pathways to attract talents to heart failure. |
| Lack of awareness about heart failure among patients |
• Launch public awareness campaigns to increase knowledge about heart failure symptoms and management options. |
| • Emphasis on Stage A heart failure and prevention |
| • Address risk factors to heart failure including high blood pressure and lipids and diabetes etc. |
| Limited research in heart failure implementation science |
• Formal training in research and implementation science and support research capacity in Asia. |
